Skip to Main Content

Author Details

Yovanni Casablanca
Uniformed Services of the Health Sciences Gynecologic Cancer Center of Excellence
2007
37
12
PMIDPaper TitleJournal TitlePublished Year
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
37067801Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer.JAMA Netw Open2023
36647676Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.Clin Cancer Res2023
34782936MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.Virchows Arch2022
35624045Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning.Gynecol Oncol2022
36244828The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study.Gynecol Oncol2022
36195845Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues.Clin Proteomics2022
36077609Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study.Cancers (Basel)2022
34991145Symptoms of Women With High-Risk Early-Stage Ovarian Cancer.Obstet Gynecol2022
34278265Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens.iScience2021
33515314Progesterone induces apoptosis by activation of caspase-8 and calcitriol via activation of caspase-9 pathways in ovarian and endometrial cancer cells in vitro.Apoptosis2021
33541735Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.Gynecol Oncol2021
33706355Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System.Obstet Gynecol2021
33931688Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients.Sci Rep2021
35036865Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry.iScience2021
34654574Corrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology 162 (2021) 532-538].Gynecol Oncol2021
34325938Racial disparities in survival among women with endometrial cancer in an equal access system.Gynecol Oncol2021
34217544Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.Gynecol Oncol2021
34117500Mandatory HPV Vaccination; Opportunity to Save Lives, Improve Readiness and Cut Costs.Mil Med2021
32294438Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer.Cell Rep2020
32029291Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.Gynecol Oncol2020
31808620Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.Cancer Med2020
31954540Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities.Gynecol Oncol2020
31954536Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities.Gynecol Oncol2020
32839027Sexual harassment and gender discrimination in gynecologic oncology.Gynecol Oncol2020
32244545Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro.Biomedicines2020
32200351A seven-step surgical strategy for robotic splenectomy.Int J Gynecol Cancer2020
30683260Chemotherapy, Biologic, and Immunotherapy Breakthroughs in Cancer Care.Obstet Gynecol Clin North Am2019
35116885TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types.Transl Cancer Res2019
32357376Gynecologic Oncology in the Department of Defense.Semin Reprod Med2019
31279844Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.Am J Obstet Gynecol2019
30838639From Discovery to Practice and Survivorship: Building a National Real-World Data Learning Healthcare Framework for Military and Veteran Cancer Patients.Clin Pharmacol Ther2019
29195926Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.Gynecol Oncol2018
23785665Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion.Front Oncol2013
23603370Transcript expression in endometrial cancers from Black and White patients.Gynecol Oncol2013
18486838Management of dysfunctional uterine bleeding.Obstet Gynecol Clin North Am2008
17197592Intracervical block and pain perception during the performance of a hysterosalpingogram: a randomized controlled trial.Obstet Gynecol2007
  • 1 - 37 of 37

Recommended Authors

Cathleen Matrai
Weill Cornell Medical Center
Career Start Year 2013
Number of shared co-authors 0
George Au-Yeung
The University of Melbourne
Career Start Year 2012
Number of shared co-authors 21
Eloise Chapman-Davis
Weill Cornell Medical College
Career Start Year 2009
Number of shared co-authors 0
Deepa Maheswari Narasimhulu
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 0
Boris Winterhoff
University of Minnesota
Career Start Year 2008
Number of shared co-authors 60
Divya Gupta
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 1
Shin-Wha Lee
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
Susana Banerjee
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 2005
Number of shared co-authors 60
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 18
Robyn A Sayer
Westmead Hospital
Career Start Year 2003
Number of shared co-authors 54
Maria Del Pilar Estevez Diz
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
Career Start Year 2002
Number of shared co-authors 0
Sven Mahner
University Hospital
Career Start Year 2002
Number of shared co-authors 59
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 11
Blaise A Clarke
University of Toronto.
Career Start Year 2001
Number of shared co-authors 28
Aparna A Kamat
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 2
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 21
Anuja Jhingran
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 4
Susan C Modesitt
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 4
Isabelle Ray-Coquard
University Claude Bernard Lyon I
Career Start Year 1997
Number of shared co-authors 60
Kathleen M Schmeler
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 4
Kevin Holcomb
Weill Cornell Medical College
Career Start Year 1996
Number of shared co-authors 1
Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 0
Annette Hasenburg
University Medical Center, Johannes Gutenberg University Mainz
Career Start Year 1994
Number of shared co-authors 1
Rosalind Glasspool
University of Glasgow
Career Start Year 1992
Number of shared co-authors 60
Patricia A Shaw
Princess Margaret Cancer Centre, University Avenue
Career Start Year 1990
Number of shared co-authors 27
Tanja Pejovic
Oregon Health & Science University
Career Start Year 1989
Number of shared co-authors 59
Fr??d??ric Amant
Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 26
Mark E Sherman
Mayo Clinic
Career Start Year 1987
Number of shared co-authors 64
Gary L Keeney
Mayo Clinic
Career Start Year 1984
Number of shared co-authors 61
Ronny Drapkin
University of Pennsylvania School of Medicine
Career Start Year 1980
Number of shared co-authors 42

Collaborators

George L Maxwell
Women's Health Integrated Research Center, Inova Health System
Co-authored papers 23
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Co-authored papers 20
Thomas P Conrads
Women's Health Integrated Research Center, Inova Health System
Co-authored papers 16
Craig D Shriver
Walter Reed National Military Medical Center
Co-authored papers 10
Brian L Hood
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Co-authored papers 7
Clifton L Dalgard
Uniformed Services University of the Health Sciences
Co-authored papers 4
Kangmin Zhu
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Co-authored papers 3
Andrew Berchuck
Duke School of Medicine
Co-authored papers 3
Andreas du Bois
Co-authored papers 2
Diether Lambrechts
Co-authored papers 2
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 2
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 2
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Co-authored papers 2
Martin K??bel
University of Calgary
Co-authored papers 2
Matthew D Wilkerson
Uniformed Services University of the Health Sciences
Co-authored papers 2
Alison Brand
Westmead Hospital
Co-authored papers 2
Stacey J Winham
Mayo Clinic
Co-authored papers 2
Douglas A Levine
Perlmutter Cancer Center
Co-authored papers 2
Catherine J Kennedy
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers 2
Uma R Chandran
Co-authored papers 2
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 2
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 2
Anna DeFazio
Westmead Hospital
Co-authored papers 2
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 2
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 2
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers 2
Michael S Anglesio
University of British Columbia
Co-authored papers 2
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 2
Aline Talhouk
The University of British Columbia
Co-authored papers 2
Release 1.2